Viagra Loses Patent Protection in Ireland, Britain

Source: PharmaManufacturing.com

Jun 22, 2013

The Irish Times

Pfizer’s little blue pill, Viagra, loses patent protection in Ireland and Britain. It is just the latest blockbuster drug to fall off the patent cliff. It’s a feeling Pfizer knows only too well, having seen sales of Lipitor plummet 60 percent last year.

Compared to the cholesterol drug – the world’s top selling prescription medication until the last couple of years – the impact of Viagra will be muted. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments